Anti-embolic and anti-oxidative effects of a novel (E)-4-amino-N′-(1-(7-hydroxy-2-oxo-2H-chromen-3-yl) ethylidene) benzohydrazide against isoproterenol and vitamin-K induced ischemic stroke

This study aimed to evaluate the cerebroprotective potential of a novel synthetic coumarin, (E)-4-amino-N′-(1-(7-hydroxy-2-oxo-2H-chromen-3-yl)ethylidene) benzohydrazide noted (HC) against a pharmaceutically induced ischemic stroke in experimental male Wistar rats. Animals were randomly allocated in...

Full description

Saved in:
Bibliographic Details
Published in:Archives of physiology and biochemistry Vol. 127; no. 6; pp. 527 - 540
Main Authors: Mnafgui, Kais, Khdhiri, Emna, Ghazouani, Lakhdar, Ncir, Marwa, Zaafouri, Zouhaier, Allouche, Noureddine, Elfeki, Abdelfattah, Ammar, Houcine, Abid, Souhir, Hajji, Raouf
Format: Journal Article
Language:English
Published: England Taylor & Francis 02.11.2021
Subjects:
ISSN:1381-3455, 1744-4160, 1744-4160
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Abstract This study aimed to evaluate the cerebroprotective potential of a novel synthetic coumarin, (E)-4-amino-N′-(1-(7-hydroxy-2-oxo-2H-chromen-3-yl)ethylidene) benzohydrazide noted (HC) against a pharmaceutically induced ischemic stroke in experimental male Wistar rats. Animals were randomly allocated into four groups: control, Stroke, Stroke + Ace (acenocoumarol) and Stroke + HC-treated group for 7 days. Our results showed that stroke group evidenced atrial flutter, significant cardiac hypertrophy (+23%) and increase in plasma level of troponin-T, with disturbance in plasma ionic levels and rise in fibrinogen rate and oxidative damages in heart and brain. Moreover, the histological findings revealed myocardium necrosis, cardiac cavity thrombi and brain injury as compared to normal rats. However, HC-treatment significantly prevents the embolic process, improves cerebral damages and mitigates the oxidative stress markers in stroke rats. Overall, HC is endowed with a thrombolytic potential against MI and stroke in such severe conditions through an anti-vit K (AVK) mechanism.
AbstractList This study aimed to evaluate the cerebroprotective potential of a novel synthetic coumarin, (E)-4-amino-N'-(1-(7-hydroxy-2-oxo-2H-chromen-3-yl)ethylidene) benzohydrazide noted (HC) against a pharmaceutically induced ischemic stroke in experimental male rats. Animals were randomly allocated into four groups: control, Stroke, Stroke + Ace (acenocoumarol) and Stroke + HC-treated group for 7 days. Our results showed that stroke group evidenced atrial flutter, significant cardiac hypertrophy (+23%) and increase in plasma level of troponin-T, with disturbance in plasma ionic levels and rise in fibrinogen rate and oxidative damages in heart and brain. Moreover, the histological findings revealed myocardium necrosis, cardiac cavity thrombi and brain injury as compared to normal rats. However, HC-treatment significantly prevents the embolic process, improves cerebral damages and mitigates the oxidative stress markers in stroke rats. Overall, HC is endowed with a thrombolytic potential against MI and stroke in such severe conditions through an anti-vit K (AVK) mechanism.
This study aimed to evaluate the cerebroprotective potential of a novel synthetic coumarin, (E)-4-amino-N'-(1-(7-hydroxy-2-oxo-2H-chromen-3-yl)ethylidene) benzohydrazide noted (HC) against a pharmaceutically induced ischemic stroke in experimental male Wistar rats. Animals were randomly allocated into four groups: control, Stroke, Stroke + Ace (acenocoumarol) and Stroke + HC-treated group for 7 days. Our results showed that stroke group evidenced atrial flutter, significant cardiac hypertrophy (+23%) and increase in plasma level of troponin-T, with disturbance in plasma ionic levels and rise in fibrinogen rate and oxidative damages in heart and brain. Moreover, the histological findings revealed myocardium necrosis, cardiac cavity thrombi and brain injury as compared to normal rats. However, HC-treatment significantly prevents the embolic process, improves cerebral damages and mitigates the oxidative stress markers in stroke rats. Overall, HC is endowed with a thrombolytic potential against MI and stroke in such severe conditions through an anti-vit K (AVK) mechanism.This study aimed to evaluate the cerebroprotective potential of a novel synthetic coumarin, (E)-4-amino-N'-(1-(7-hydroxy-2-oxo-2H-chromen-3-yl)ethylidene) benzohydrazide noted (HC) against a pharmaceutically induced ischemic stroke in experimental male Wistar rats. Animals were randomly allocated into four groups: control, Stroke, Stroke + Ace (acenocoumarol) and Stroke + HC-treated group for 7 days. Our results showed that stroke group evidenced atrial flutter, significant cardiac hypertrophy (+23%) and increase in plasma level of troponin-T, with disturbance in plasma ionic levels and rise in fibrinogen rate and oxidative damages in heart and brain. Moreover, the histological findings revealed myocardium necrosis, cardiac cavity thrombi and brain injury as compared to normal rats. However, HC-treatment significantly prevents the embolic process, improves cerebral damages and mitigates the oxidative stress markers in stroke rats. Overall, HC is endowed with a thrombolytic potential against MI and stroke in such severe conditions through an anti-vit K (AVK) mechanism.
This study aimed to evaluate the cerebroprotective potential of a novel synthetic coumarin, (E)-4-amino-N′-(1-(7-hydroxy-2-oxo-2H-chromen-3-yl)ethylidene) benzohydrazide noted (HC) against a pharmaceutically induced ischemic stroke in experimental male Wistar rats. Animals were randomly allocated into four groups: control, Stroke, Stroke + Ace (acenocoumarol) and Stroke + HC-treated group for 7 days. Our results showed that stroke group evidenced atrial flutter, significant cardiac hypertrophy (+23%) and increase in plasma level of troponin-T, with disturbance in plasma ionic levels and rise in fibrinogen rate and oxidative damages in heart and brain. Moreover, the histological findings revealed myocardium necrosis, cardiac cavity thrombi and brain injury as compared to normal rats. However, HC-treatment significantly prevents the embolic process, improves cerebral damages and mitigates the oxidative stress markers in stroke rats. Overall, HC is endowed with a thrombolytic potential against MI and stroke in such severe conditions through an anti-vit K (AVK) mechanism.
Author Ncir, Marwa
Elfeki, Abdelfattah
Khdhiri, Emna
Allouche, Noureddine
Ghazouani, Lakhdar
Ammar, Houcine
Abid, Souhir
Hajji, Raouf
Mnafgui, Kais
Zaafouri, Zouhaier
Author_xml – sequence: 1
  givenname: Kais
  surname: Mnafgui
  fullname: Mnafgui, Kais
  organization: Laboratory of Animal Physiology, Faculty of Sciences of Sfax, University of Sfax
– sequence: 2
  givenname: Emna
  surname: Khdhiri
  fullname: Khdhiri, Emna
  organization: Laboratory of Applied Chemistry HCGP, Faculty of Science, University of Sfax
– sequence: 3
  givenname: Lakhdar
  surname: Ghazouani
  fullname: Ghazouani, Lakhdar
  organization: Research Unit of Macromolecular Biochemistry and Genetics, Faculty of Sciences of Gafsa
– sequence: 4
  givenname: Marwa
  surname: Ncir
  fullname: Ncir, Marwa
  organization: Laboratory of Animal Physiology, Faculty of Sciences of Sfax, University of Sfax
– sequence: 5
  givenname: Zouhaier
  surname: Zaafouri
  fullname: Zaafouri, Zouhaier
  organization: Department of Surgery, Hospital of Sidi Bouzid
– sequence: 6
  givenname: Noureddine
  surname: Allouche
  fullname: Allouche, Noureddine
  organization: Laboratory of Organic Chemistry LR17ES08 (Natural Substances Team), Faculty of Sciences of Sfax, University of Sfax
– sequence: 7
  givenname: Abdelfattah
  surname: Elfeki
  fullname: Elfeki, Abdelfattah
  organization: Laboratory of Animal Physiology, Faculty of Sciences of Sfax, University of Sfax
– sequence: 8
  givenname: Houcine
  surname: Ammar
  fullname: Ammar, Houcine
  organization: Laboratory of Applied Chemistry HCGP, Faculty of Science, University of Sfax
– sequence: 9
  givenname: Souhir
  surname: Abid
  fullname: Abid, Souhir
  organization: Chemistry Department, College of Science and Arts, Jouf University
– sequence: 10
  givenname: Raouf
  surname: Hajji
  fullname: Hajji, Raouf
  organization: Faculty of Medicine of Sousse, Department of Internal Medicine, Hospital of Sidi Bouzid
BackLink https://www.ncbi.nlm.nih.gov/pubmed/31469295$$D View this record in MEDLINE/PubMed
BookMark eNqFkc1yFCEUhbusWOZHH0GL5cyCEbpppik3plIxsUzpRtcUDbcdlIYIzJjOymfyBfIuPomMM7NxoQsK6vKdew-c0-rIBw9V9ZySBSUdeUmbjjasbRc1oWJBebsUhDyqTuiSMcwoJ0flXBi8hY6r05S-EELrTtAn1XFDGRe1aE-qh3OfLYaxD85qpLwpqxTCnTUq2w0gGAbQOaEwIIV82IBDs8s5ZliN1gf8_tePn3hG8WyJV5OJ4W7CdVEHXF9jvYphBI8bPLk5gryanDXgYY568Pdhy6v7UkHqs7I-ZWRTuI0hQwQf3B8zG5u3c_A7ZL1ZazCF0SsYi9eUY_gKT6vHg3IJnu33s-rTm8uPF9f45sPV24vzG6wbzjMeOBXl1wQIPjA9CNq0PekNmNY0BHRfsx5Y13QdZ7UeTFuu-JL2IJToNOemOatmu77F4Lc1pCzH4gScUx7COsm67hpKGaWkoC_26LofwcjbaEcVJ3n49AK82gE6hpQiDFKXZ2YbfI7KOkmJ3EYsDxHLbcRyH3FRt3-pDwP-p3u901k_hDiq7yE6I7OaXIhDVF7bVCz-s8Vv3eq_YQ
CitedBy_id crossref_primary_10_1155_2020_2432918
crossref_primary_10_1007_s42250_024_01011_3
crossref_primary_10_1080_00397911_2022_2095213
crossref_primary_10_1007_s11064_021_03351_9
crossref_primary_10_1002_jbt_22747
crossref_primary_10_1016_j_sajb_2025_07_006
Cites_doi 10.1111/j.1365-2125.1992.tb05634.x
10.1159/000352050
10.1007/s11239-005-2473-4
10.1046/j.1538-7836.2003.00052.x
10.1001/archinte.160.21.3196
10.1161/CIRCULATIONAHA.110.986661
10.1016/j.amjcard.2013.02.067
10.1097/WCO.0b013e32813ba151
10.1038/jcbfm.2013.203
10.1016/S0021-9258(19)52451-6
10.1161/STROKEAHA.108.533505
10.1111/j.1538-7836.2011.04361.x
10.1136/bmj.320.7248.1502
10.1016/S0072-9752(08)01903-9
10.1016/j.biopha.2017.11.093
10.1096/fj.02-1086fje
10.3390/nu10111575
10.1007/s12975-013-0308-8
10.1016/j.ccl.2015.12.003
10.1212/01.WNL.0000063309.41867.0F
10.1007/s12012-015-9343-x
10.1126/science.179.4073.588
10.1001/jama.285.22.2864
10.1038/sj.bjp.0707594
10.1152/physrev.1999.79.4.1431
10.1007/112_2018_13
10.1159/000226773
10.1016/j.freeradbiomed.2005.06.025
10.1016/S0024-3205(99)00455-5
10.1358/dot.2008.44.10.1265487
10.1016/S0021-9150(97)00087-7
10.1007/978-3-319-49674-0_13
10.1016/j.jep.2016.04.060
10.1016/S0074-7742(07)82016-2
10.1016/j.jstrokecerebrovasdis.2017.09.011
10.1016/j.cjca.2018.02.016
10.1038/nrneurol.2012.33
10.1007/s13311-011-0053-1
10.1016/j.clineuro.2017.05.019
10.2174/092986710790936284
10.1179/174329210X12650506623168
10.2147/TCRM.S84210
10.1016/j.jns.2006.01.020
10.5114/fn.2012.30522
10.1161/01.STR.32.1.133
10.4103/1673-5374.150724
10.1016/j.arr.2013.09.004
10.1161/ATVBAHA.117.308564
10.1016/j.cjca.2018.01.001
10.1055/s-2001-18870
10.1155/2013/963248
10.1016/j.clinthera.2017.05.358
10.2165/00003088-200544120-00003
10.1016/0891-5849(88)90023-8
ContentType Journal Article
Copyright 2019 Informa UK Limited, trading as Taylor & Francis Group 2019
Copyright_xml – notice: 2019 Informa UK Limited, trading as Taylor & Francis Group 2019
DBID AAYXX
CITATION
CGR
CUY
CVF
ECM
EIF
NPM
7X8
DOI 10.1080/13813455.2019.1657900
DatabaseName CrossRef
Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
MEDLINE - Academic
DatabaseTitle CrossRef
MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
MEDLINE - Academic
DatabaseTitleList MEDLINE
MEDLINE - Academic

Database_xml – sequence: 1
  dbid: NPM
  name: PubMed
  url: http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 2
  dbid: 7X8
  name: MEDLINE - Academic
  url: https://search.proquest.com/medline
  sourceTypes: Aggregation Database
DeliveryMethod fulltext_linktorsrc
Discipline Anatomy & Physiology
Chemistry
EISSN 1744-4160
EndPage 540
ExternalDocumentID 31469295
10_1080_13813455_2019_1657900
1657900
Genre Research Article
Randomized Controlled Trial, Veterinary
Journal Article
GroupedDBID ---
00X
03L
0R~
23N
36B
4.4
53G
5GY
6J9
AAGDL
AALUX
AAMIU
AAPUL
AAQRR
ABBKH
ABDBF
ABEIZ
ABJNI
ABLIJ
ABLKL
ABUPF
ABWVI
ABXYU
ACENM
ACGEJ
ACGFO
ACGFS
ACIEZ
ACUHS
ADCVX
ADRBQ
ADXPE
AECIN
AENEX
AEOZL
AFKVX
AFRVT
AGDLA
AGFJD
AGRBW
AGYJP
AIJEM
AIRBT
AJWEG
AKBVH
ALMA_UNASSIGNED_HOLDINGS
ALQZU
ALYBC
AMDAE
AQTUD
BABNJ
BLEHA
BOHLJ
CCCUG
CS3
DKSSO
EAP
EAS
EBB
EBC
EBD
EBS
EBX
EHN
EMB
EMK
EMOBN
EPL
EPT
EST
ESX
F5P
H13
HZ~
KRBQP
KSSTO
KWAYT
KYCEM
LJTGL
M4Z
O9-
Q~Q
RNANH
RVRKI
SV3
TASJS
TBQAZ
TDBHL
TERGH
TFDNU
TFL
TFW
TUROJ
TUS
UEQFS
V1S
~1N
AAYXX
CITATION
.GJ
5VS
AALIY
AAORF
AAPXX
ABWCV
ABZEW
ACKZS
ACOPL
ACYZI
ADFOM
ADFZZ
ADYSH
AEIIZ
AFLEI
AJVHN
AWYRJ
BRMBE
CAG
CGR
COF
CUY
CVF
CYYVM
CZDIS
DRXRE
DWTOO
ECM
EIF
EJD
JENTW
M44
NPM
NUSFT
QQXMO
ZXP
7X8
ID FETCH-LOGICAL-c366t-f6190809e96f4cf9135b0bded5d30ecb24be48388642cfd5bde671be9a98c66d3
IEDL.DBID TFW
ISICitedReferencesCount 9
ISICitedReferencesURI http://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=Summon&SrcAuth=ProQuest&DestLinkType=CitingArticles&DestApp=WOS_CPL&KeyUT=000484264400001&url=https%3A%2F%2Fcvtisr.summon.serialssolutions.com%2F%23%21%2Fsearch%3Fho%3Df%26include.ft.matches%3Dt%26l%3Dnull%26q%3D
ISSN 1381-3455
1744-4160
IngestDate Thu Sep 04 17:30:33 EDT 2025
Mon Jul 21 05:56:07 EDT 2025
Tue Nov 18 21:46:44 EST 2025
Sat Nov 29 01:43:44 EST 2025
Mon Oct 20 23:47:21 EDT 2025
IsPeerReviewed true
IsScholarly true
Issue 6
Keywords Stroke
fibrinogen
atrial flutter
coumarin
myocardial infarction
Language English
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-c366t-f6190809e96f4cf9135b0bded5d30ecb24be48388642cfd5bde671be9a98c66d3
Notes ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
PMID 31469295
PQID 2283114110
PQPubID 23479
PageCount 14
ParticipantIDs crossref_citationtrail_10_1080_13813455_2019_1657900
proquest_miscellaneous_2283114110
crossref_primary_10_1080_13813455_2019_1657900
informaworld_taylorfrancis_310_1080_13813455_2019_1657900
pubmed_primary_31469295
PublicationCentury 2000
PublicationDate 2021-11-02
PublicationDateYYYYMMDD 2021-11-02
PublicationDate_xml – month: 11
  year: 2021
  text: 2021-11-02
  day: 02
PublicationDecade 2020
PublicationPlace England
PublicationPlace_xml – name: England
PublicationTitle Archives of physiology and biochemistry
PublicationTitleAlternate Arch Physiol Biochem
PublicationYear 2021
Publisher Taylor & Francis
Publisher_xml – name: Taylor & Francis
References Hatano S. (CIT0015) 1976; 54
CIT0030
CIT0032
CIT0031
CIT0034
CIT0033
Mishra L.D. (CIT0038) 2002; 46
CIT0036
CIT0037
CIT0039
CIT0041
CIT0040
CIT0043
CIT0042
CIT0045
CIT0044
CIT0003
CIT0047
CIT0002
CIT0046
Ábrahám H. (CIT0001) 2002; 142
CIT0005
CIT0049
CIT0004
CIT0048
CIT0007
CIT0006
CIT0009
CIT0008
CIT0050
CIT0051
CIT0010
CIT0054
CIT0053
CIT0012
CIT0056
CIT0011
CIT0055
Trailokya A. (CIT0052) 2016; 64
CIT0014
CIT0058
CIT0013
CIT0057
CIT0016
CIT0059
CIT0018
CIT0017
CIT0019
CIT0060
CIT0021
CIT0020
CIT0023
CIT0022
Mărgăritescu O.A. (CIT0035) 2009; 50
CIT0024
Kakkar P. (CIT0025) 1984; 21
CIT0027
CIT0026
CIT0029
CIT0028
References_xml – ident: CIT0037
  doi: 10.1111/j.1365-2125.1992.tb05634.x
– ident: CIT0003
  doi: 10.1159/000352050
– ident: CIT0005
  doi: 10.1007/s11239-005-2473-4
– ident: CIT0016
  doi: 10.1046/j.1538-7836.2003.00052.x
– ident: CIT0010
  doi: 10.1001/archinte.160.21.3196
– ident: CIT0021
  doi: 10.1161/CIRCULATIONAHA.110.986661
– ident: CIT0029
  doi: 10.1016/j.amjcard.2013.02.067
– ident: CIT0040
  doi: 10.1097/WCO.0b013e32813ba151
– volume: 46
  start-page: 87
  year: 2002
  ident: CIT0038
  publication-title: Indian journal of anaesthesia
– ident: CIT0023
  doi: 10.1038/jcbfm.2013.203
– ident: CIT0034
  doi: 10.1016/S0021-9258(19)52451-6
– volume: 50
  start-page: 327
  issue: 3
  year: 2009
  ident: CIT0035
  publication-title: Romanian journal of morphology and embryology
– volume: 54
  start-page: 541
  issue: 5
  year: 1976
  ident: CIT0015
  publication-title: Bulletin of world health organisation
– ident: CIT0059
  doi: 10.1161/STROKEAHA.108.533505
– ident: CIT0041
  doi: 10.1111/j.1538-7836.2011.04361.x
– ident: CIT0022
  doi: 10.1136/bmj.320.7248.1502
– ident: CIT0008
  doi: 10.1016/S0072-9752(08)01903-9
– ident: CIT0049
  doi: 10.1016/j.biopha.2017.11.093
– ident: CIT0020
  doi: 10.1096/fj.02-1086fje
– ident: CIT0031
  doi: 10.3390/nu10111575
– ident: CIT0044
  doi: 10.1007/s12975-013-0308-8
– ident: CIT0018
  doi: 10.1016/j.ccl.2015.12.003
– ident: CIT0024
  doi: 10.1212/01.WNL.0000063309.41867.0F
– ident: CIT0039
  doi: 10.1007/s12012-015-9343-x
– ident: CIT0051
  doi: 10.1126/science.179.4073.588
– ident: CIT0012
  doi: 10.1001/jama.285.22.2864
– ident: CIT0013
  doi: 10.1038/sj.bjp.0707594
– ident: CIT0032
  doi: 10.1152/physrev.1999.79.4.1431
– ident: CIT0033
  doi: 10.1007/112_2018_13
– ident: CIT0027
  doi: 10.1159/000226773
– volume: 21
  start-page: 130
  issue: 2
  year: 1984
  ident: CIT0025
  publication-title: Indian journal of biochemistry and biophysics
– ident: CIT0006
  doi: 10.1016/j.freeradbiomed.2005.06.025
– ident: CIT0042
  doi: 10.1016/S0024-3205(99)00455-5
– ident: CIT0030
  doi: 10.1358/dot.2008.44.10.1265487
– ident: CIT0050
  doi: 10.1016/S0021-9150(97)00087-7
– ident: CIT0058
  doi: 10.1007/978-3-319-49674-0_13
– ident: CIT0028
  doi: 10.1016/j.jep.2016.04.060
– ident: CIT0047
  doi: 10.1016/S0074-7742(07)82016-2
– ident: CIT0019
  doi: 10.1016/j.jstrokecerebrovasdis.2017.09.011
– ident: CIT0060
  doi: 10.1016/j.cjca.2018.02.016
– ident: CIT0057
  doi: 10.1038/nrneurol.2012.33
– volume: 142
  start-page: 131
  issue: 9
  year: 2002
  ident: CIT0001
  publication-title: Experimental brain research
– ident: CIT0043
  doi: 10.1007/s13311-011-0053-1
– ident: CIT0046
  doi: 10.1016/j.clineuro.2017.05.019
– ident: CIT0048
  doi: 10.2174/092986710790936284
– ident: CIT0055
  doi: 10.1179/174329210X12650506623168
– ident: CIT0036
  doi: 10.2147/TCRM.S84210
– ident: CIT0053
  doi: 10.1016/j.jns.2006.01.020
– ident: CIT0045
  doi: 10.5114/fn.2012.30522
– ident: CIT0007
  doi: 10.1161/01.STR.32.1.133
– ident: CIT0004
  doi: 10.4103/1673-5374.150724
– ident: CIT0009
  doi: 10.1016/j.arr.2013.09.004
– ident: CIT0026
  doi: 10.1161/ATVBAHA.117.308564
– ident: CIT0014
  doi: 10.1016/j.cjca.2018.01.001
– ident: CIT0017
  doi: 10.1055/s-2001-18870
– ident: CIT0056
  doi: 10.1155/2013/963248
– ident: CIT0002
  doi: 10.1016/j.clinthera.2017.05.358
– volume: 64
  start-page: 88
  issue: 2
  year: 2016
  ident: CIT0052
  publication-title: Journal of the association of physicians of India
– ident: CIT0054
  doi: 10.2165/00003088-200544120-00003
– ident: CIT0011
  doi: 10.1016/0891-5849(88)90023-8
SSID ssj0012891
Score 2.3159997
Snippet This study aimed to evaluate the cerebroprotective potential of a novel synthetic coumarin, (E)-4-amino-N′-(1-(7-hydroxy-2-oxo-2H-chromen-3-yl)ethylidene)...
This study aimed to evaluate the cerebroprotective potential of a novel synthetic coumarin, (E)-4-amino-N'-(1-(7-hydroxy-2-oxo-2H-chromen-3-yl)ethylidene)...
SourceID proquest
pubmed
crossref
informaworld
SourceType Aggregation Database
Index Database
Enrichment Source
Publisher
StartPage 527
SubjectTerms Animals
atrial flutter
Brain Ischemia - drug therapy
Brain Ischemia - metabolism
coumarin
fibrinogen
Ischemic Stroke
Isoproterenol
Male
myocardial infarction
Myocardium - metabolism
Oxidative Stress
Rats
Rats, Wistar
Stroke
Stroke - drug therapy
Stroke - metabolism
Vitamin K - metabolism
Vitamins
Title Anti-embolic and anti-oxidative effects of a novel (E)-4-amino-N′-(1-(7-hydroxy-2-oxo-2H-chromen-3-yl) ethylidene) benzohydrazide against isoproterenol and vitamin-K induced ischemic stroke
URI https://www.tandfonline.com/doi/abs/10.1080/13813455.2019.1657900
https://www.ncbi.nlm.nih.gov/pubmed/31469295
https://www.proquest.com/docview/2283114110
Volume 127
WOSCitedRecordID wos000484264400001&url=https%3A%2F%2Fcvtisr.summon.serialssolutions.com%2F%23%21%2Fsearch%3Fho%3Df%26include.ft.matches%3Dt%26l%3Dnull%26q%3D
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
journalDatabaseRights – providerCode: PRVAWR
  databaseName: Taylor & Francis Online Journals
  customDbUrl:
  eissn: 1744-4160
  dateEnd: 99991231
  omitProxy: false
  ssIdentifier: ssj0012891
  issn: 1381-3455
  databaseCode: TFW
  dateStart: 19950101
  isFulltext: true
  titleUrlDefault: https://www.tandfonline.com
  providerName: Taylor & Francis
link http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV1Lb9QwELagQoILj5bH8qiMhNDuwWUTOw8fV1VXlZBWHIrYW-RXaNSsjTbpiu2J38Qf4L_wSxg7yYoeqh7gkIvjsZ3MOP7GnnyD0DuWCR3nqSSJylLCmGJEqEiRVE0BPjMJTocKySayxSJfLvmnPpqw6cMqvQ9ddkQR4VvtJ7eQzRAR9yGCVYayJPGBWfwoSpOMT73XDsje2_jZ_MvuHCHucuZ5CeJFhn94bmrl2up0jbv0ZgQaVqL5o__wDI_Rwx6G4llnN0_QHWP30cHMggu-2uL3OASGhh33fXT_eEgKd4B-zWxbEbOSnk4YQ-9wQYH7XunAII77-BDsSiywdRtT4_HJhIBuVpV1ZPH7x08yjsg4I-db7UNoSAzSjsSnRJ176gRLKNnWE2zAgmqf8dRMsDT2yvn64gpKsPgqKkC1uGpcoJlYG-vqMJhN1fp-yEdcWQ1Gq6GOCpQIGMbvLsxT9Hl-cnZ8SvocEETRNG1JCQ4evC9ueFoyVfKIJnIqtdGJplOjZMykYTnNc_CjVKkTuJVmkTRc8FylqabP0J511rxAmE1NIoSJoxJgo8yp4GWWmEzrEtrMuBkhNui-UD1Bus_TURdRz6M6KK3wSit6pY3Q0U7sW8cQcpsA_9uwijZszZRdHpWC3iL7drDCAjTvD3eENe6yKTyNEfi2gOZG6HlnnrvhUFgOAQYnL_-h51foQezDefyOevwa7bXrS_MG3VObtmrWh-hutswPw9z7AwIAKhI
linkProvider Taylor & Francis
linkToHtml http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV1Lb9QwELZQQSoXHi2P5WkkhHYPLnnYSXxcVV0tatnTInqLHNtpI7I22k1XbE_8Jv4A_4VfwthJVu2h6gEOuTie2MmMMw-Pv0HoPU2FirKkIEymCaFUUiJkKEkiAzCfaQFOh_TFJtLZLDs95VfPwri0SudDly1QhP9Xu8XtgtF9StzHENRMTBlzmVn8IExYygNw2-8y0LUurW8--brdSYjaqnmOhDia_hTPTY-5pp-uoZfebIN6XTR5-D_e4hF60FmieNyKzmN0R5s9tD824IUvNvgD9rmhPui-h3YP-7pw--j32DQV0YvCIQpjGB4uaLA_KuVBxHGXIoJtiQU2dq1rPDwaEWDPojKWzP78_EWGIRmm5HyjXBYNiYDakmhK5LlDTzAkJpt6hDUIUe2KnuoRLrS5tK6_uIQWLM5EBYYtrlbWI00stbG1n8y6atw45BhXRoHcKugjPSoChvnbb_oJ-jI5mh9OSVcGgsg4SRpSgo8H34trnpRUljyMWREUSium4kDLIqKFplmcZeBKyVIxuJWkYaG54JlMEhU_RTvGGv0cYRpoJoSOwhIsxyKLBS9TplOlSnhmyvUA0Z75ueww0l2pjjoPOyjVnmm5Y1reMW2ADrZk31uQkNsI-FXJyhsfnSnbUip5fAvtu14Mc-C8298RRtuLVe6QjMC9BYNugJ618rmdTgwaESxh9uIfRn6Ldqfzzyf5yafZ8Ut0P3LZPS7AHr1CO83yQr9G9-S6qVbLN34J_gWlqy1L
linkToPdf http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV1Lb9QwELZQQcCFR8tjeRoJod2DyyZxnPi4Kl0VFa16KKK3yPGDRmTtajddsT3xm_gD_Bd-CWMnWdFD1QMccnE8tpMZxzP2l28QekszoeKclSSVGSOUSkqEjCRhcgzuMy0h6JAh2UQ2m-UnJ_yoQxMuO1ilj6FNSxQRvtV-cp8p0yPi3kewyiQ0TT0wi-9GLM34GKL2m4EcC0z6ePplc5AQt0nzvAjxMv1PPFc1c2l5ukReerULGpai6f3_8BAP0L3OD8WT1nAeohvabqOdiYUYfL7G73BAhoYt9210Z6_PCreDfk1sUxE9Lz2fMIbe4YIC971SgUIcdwAR7AwW2LqVrvFwf0RAOfPKOjL7_eMnGUZkmJHTtfIYGhKDtCPxAZGnnjvBkoSs6xHWYEK1T3mqR7jU9sL5-uICSrD4Kipwa3G1dIFnYqGtq8NgVlXj-yGHuLIKrFZBHRk4ETCM333Tj9Dn6f7x3gHpkkAQmTDWEAMRHrwvrjkzVBoeJWk5LpVWqUrGWpYxLTXNkzyHQEoalcItlkWl5oLnkjGVPEZb1ln9FGE61qkQOo4M-I1lnghuslRnShloM-N6gGiv-0J2DOk-UUddRB2Raq-0wiut6JQ2QLsbsbOWIuQ6Af63YRVN2JsxbSKVIrlG9k1vhQVo3p_uCKvd-bLwPEYQ3II7N0BPWvPcDCeB9RD84PTZP_T8Gt0--jAtPn2cHT5Hd2MP7fG76_ELtNUszvVLdEuummq5eBUm4B_Akyvv
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Anti-embolic+and+anti-oxidative+effects+of+a+novel+%28E%29-4-amino-N%E2%80%B2-%281-%287-hydroxy-2-oxo-2H-chromen-3-yl%29+ethylidene%29+benzohydrazide+against+isoproterenol+and+vitamin-K+induced+ischemic+stroke&rft.jtitle=Archives+of+physiology+and+biochemistry&rft.au=Mnafgui%2C+Kais&rft.au=Khdhiri%2C+Emna&rft.au=Ghazouani%2C+Lakhdar&rft.au=Ncir%2C+Marwa&rft.date=2021-11-02&rft.issn=1381-3455&rft.eissn=1744-4160&rft.volume=127&rft.issue=6&rft.spage=527&rft.epage=540&rft_id=info:doi/10.1080%2F13813455.2019.1657900&rft.externalDBID=n%2Fa&rft.externalDocID=10_1080_13813455_2019_1657900
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1381-3455&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1381-3455&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1381-3455&client=summon